Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Gene-specific contributions to mumps virus neurovirulence and neuroattenuation.

Sauder CJ, Zhang CX, Ngo L, Werner K, Lemon K, Duprex WP, Malik T, Carbone K, Rubin SA.

J Virol. 2011 Jul;85(14):7059-69. doi: 10.1128/JVI.00245-11. Epub 2011 May 4.

2.

Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.

Rubin SA, Amexis G, Pletnikov M, Li Z, Vanderzanden J, Mauldin J, Sauder C, Malik T, Chumakov K, Carbone KM.

J Virol. 2003 Nov;77(21):11616-24. Erratum in: J Virol. 2003 Dec;77(24):13456. J Virol. 2007 Aug;81(16):8849.

3.

Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence.

Malik T, Shegogue CW, Werner K, Ngo L, Sauder C, Zhang C, Duprex WP, Rubin S.

J Virol. 2011 Jun;85(12):6082-5. doi: 10.1128/JVI.02686-10. Epub 2011 Apr 6.

4.
5.

Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.

Sauder CJ, Zhang CX, Link MA, Duprex WP, Carbone KM, Rubin SA.

Vaccine. 2009 Sep 25;27(42):5822-9. doi: 10.1016/j.vaccine.2009.07.051. Epub 2009 Aug 4.

PMID:
19660591
6.

A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo.

Malik T, Sauder C, Wolbert C, Zhang C, Carbone KM, Rubin S.

J Neurovirol. 2007 Dec;13(6):513-21.

PMID:
18097883
7.

The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.

Lemon K, Rima BK, McQuaid S, Allen IV, Duprex WP.

J Virol. 2007 Aug;81(15):8293-302. Epub 2007 May 2.

8.

Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants.

Ivancic-Jelecki J, Forcic D, Jagusic M, Kosutic-Gulija T, Mazuran R, Balija ML, Isakov O, Shomron N.

Vaccine. 2016 Apr 29;34(20):2383-9. doi: 10.1016/j.vaccine.2016.03.033. Epub 2016 Mar 21.

PMID:
27013432
9.

The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.

Rubin SA, Snoy PJ, Wright KE, Brown EG, Reeve P, Beeler JA, Carbone KM.

J Infect Dis. 1999 Aug;180(2):521-5.

PMID:
10395874
10.

Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity.

Sauder CJ, Vandenburgh KM, Iskow RC, Malik T, Carbone KM, Rubin SA.

Virology. 2006 Jun 20;350(1):48-57. Epub 2006 Feb 21.

11.

Neurovirulence safety testing of mumps vaccines--historical perspective and current status.

Rubin SA, Afzal MA.

Vaccine. 2011 Apr 5;29(16):2850-5. doi: 10.1016/j.vaccine.2011.02.005. Epub 2011 Feb 18. Review.

PMID:
21334386
12.

Development and biological properties of a new live attenuated mumps vaccine.

Saika S, Kidokoro M, Kubonoya H, Ito K, Ohkawa T, Aoki A, Nagata N, Suzuki K.

Comp Immunol Microbiol Infect Dis. 2006 Mar-May;29(2-3):89-99. Epub 2006 May 2.

PMID:
16647119
13.

Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.

Saika S, Kidokoro M, Aoki A, Ohkawa T.

Biologicals. 2004 Sep;32(3):147-52.

PMID:
15536045
14.

Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain.

Malik T, Wolbert C, Mauldin J, Sauder C, Carbone KM, Rubin SA.

J Gen Virol. 2007 Sep;88(Pt 9):2533-41.

PMID:
17698664
15.

Accumulation of defective interfering viral particles in only a few passages in Vero cells attenuates mumps virus neurovirulence.

Šantak M, Markušić M, Balija ML, Kopač SK, Jug R, Örvell C, Tomac J, Forčić D.

Microbes Infect. 2015 Mar;17(3):228-36. doi: 10.1016/j.micinf.2014.11.006. Epub 2014 Dec 3.

PMID:
25479555
16.

The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.

Rubin SA, Afzal MA, Powell CL, Bentley ML, Auda GR, Taffs RE, Carbone KM.

J Infect Dis. 2005 Apr 1;191(7):1123-8. Epub 2005 Feb 22.

PMID:
15747248
17.

Two clones obtained from Urabe AM9 mumps virus vaccine differ in their replicative efficiency in neuroblastoma cells.

Santos-López G, Cruz C, Pazos N, Vallejo V, Reyes-Leyva J, Tapia-Ramírez J.

Microbes Infect. 2006 Feb;8(2):332-9. Epub 2005 Oct 18.

PMID:
16298153
18.

Pathogenicity of mumps virus in the marmoset.

Saika S, Kidokoro M, Ohkawa T, Aoki A, Suzuki K.

J Med Virol. 2002 Jan;66(1):115-22.

PMID:
11748667
19.

[Comparative evaluation of Leningrad-3 mumps vaccine virus neurovirulence in a neonatal rat model].

Ignat'ev GM, Otrashevskaia EV, Rubin SA.

Vopr Virusol. 2011 Jul-Aug;56(4):30-3. Russian.

PMID:
21899067
20.

Monkey neurovirulence test for live mumps vaccine.

Maximova O, Dragunsky E, Taffs R, Snoy P, Cogan J, Marsden S, Levenbook I.

Biologicals. 1996 Sep;24(3):223-4. No abstract available.

PMID:
8978921

Supplemental Content

Support Center